The ALS Center for Cell Therapy and Regeneration Research at Johns Hopkins is committed to identifying the causes of the neurodegenerative disease, amyotrophic lateral sclerosis (ALS), and discovering new and effective treatment options.
The Center's research focuses on the use of stem cells to research the disease, drug screening, and cell transplantation, as well as the development of pharmaceuticals for treating ALS. However the ultimate goal is to promote parallel research into ultimately preventing ALS altogether, as well as investigate the regrowth or repair of nervous tissues, cells or cell products affected by the disease.
Affiliated Centers
At the ALS Center, Johns Hopkins researchers work with other investigators to aggressively take groundbreaking scientific discoveries and turn them into clinical applications that will improve the quality of life of those diagnosed with ALS.
Our Team
The core group of investigators at the ALS Center brings a unique perspective to ALS therapeutics with specific expertise in working with patients with ALS and other motor neuron diseases, as well as basic science and clinical research interests and programs for this disease.
Ahmet Hoke, M.D., Ph.D.
Professor of Neurology
Professor of Neuroscience
Nicholas John Maragakis, M.D.
Director, ALS Center for Cell Therapy and Regeneration Research
Medical Director, ALS Clinical Trials Unit
Professor of Neurology
Jeffrey David Rothstein, M.D., Ph.D.
Professor of Neurology
Professor of Neuroscience
Charlotte Jane Sumner, M.D.
Professor of Genetic Medicine
Professor of Neuroscience
Contact Us
The John G. Rangos Sr. Building
855 North Wolfe St.
Room 248 (second floor)
Baltimore, MD 21205
Phone: 443-287-4341
Appointments: 410-955-8511